| Literature DB >> 6610713 |
Abstract
Treatment of cloned murine CTL with phorbol myristate acetate (PMA) initiates the loss of lytic potential of these cells. The process is relatively rapid (t 1/2 = 2.2 +/- 0.7 hr), occurs independently of protein synthesis, and can be largely reversed within 3 hr by incubation in normal medium with or without the addition of supernatants from activated lymphocytes. Examination of PMA-treated or untreated CTL in assays that separate binding and post-binding events suggests that the lytic apparatus itself is a major target of the PMA-initiated event.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6610713
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422